Drug Utilization Review Board Meeting Rescheduled to Friday, Nov. 12 The Texas Drug Utilization Review Board quarterly meeting, initially scheduled for October 22, has been postponed until Friday, November 12. HHSC will conduct the meeting virtually using Microsoft Teams with an on-site option. Other news Pharmacy Submittal of COVID-19 Vaccine Additional, Booster Doses Repatha Prior Authorization Update Scheduled for Dec. 6 Nucala Clinical Prior Authorization Update Scheduled for Dec. 14 Hepatitis C Drug Rebate Program Procurement Information Now Available

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to stevenmagallanes520.nims@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202